Status:
COMPLETED
PROFILE-MI - The FAPI Fibrosis Study
Lead Sponsor:
University of Edinburgh
Conditions:
Myocardial Infarction
Myocardial Fibrosis
Eligibility:
All Genders
50+ years
Brief Summary
The investigators here propose to investigate the timing and pattern of myocardial fibrosis activity following acute myocardial infarction using hybrid 68Ga-FAPI positron emission tomography and cardi...
Detailed Description
Fibrosis is a fundamental process underlying almost all cardiomyopathic conditions. Established fibrosis can be detected by existing imaging techniques including cardiovascular magnetic resonance. How...
Eligibility Criteria
Inclusion
- specific to cohort;
- aged 50 years or older
Exclusion
- Claustrophobia
- Inability to undergo MRI
- eGFR \<30ml/min/1.73\^m2
Key Trial Info
Start Date :
April 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05356923
Start Date
April 21 2021
End Date
December 31 2023
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Infirmary of Edinburgh
Edinburgh, City Of Edinburgh, United Kingdom, EH16 4SA